These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23951517)

  • 1. Increase in sclerostin levels is associated with fracture healing in humans.
    Bonekey Rep; 2012; 1():137. PubMed ID: 23951517
    [No Abstract]   [Full Text] [Related]  

  • 2. Does Sclerostin Depletion Stimulate Fracture Healing in a Mouse Model?
    Alzahrani MM; Rauch F; Hamdy RC
    Clin Orthop Relat Res; 2016 May; 474(5):1294-302. PubMed ID: 26608966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene.
    Li C; Ominsky MS; Tan HL; Barrero M; Niu QT; Asuncion FJ; Lee E; Liu M; Simonet WS; Paszty C; Ke HZ
    Bone; 2011 Dec; 49(6):1178-85. PubMed ID: 21890008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular enhancement of fracture healing - Is there a role for Bone Morphogenetic Protein-2, parathyroid hormone, statins, or sclerostin-antibodies?
    Henssler L; Kerschbaum M; Mukashevich MZ; Rupp M; Alt V
    Injury; 2021 Jun; 52 Suppl 2():S49-S57. PubMed ID: 34001374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerostin monoclonal antibodies on bone metabolism and fracture healing.
    Gamie Z; Korres N; Leonidou A; Gray AC; Tsiridis E
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1523-34. PubMed ID: 22849579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-sclerostin - is there an indication?
    Larsson S
    Injury; 2016 Jan; 47 Suppl 1():S31-5. PubMed ID: 26768288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats.
    Suen PK; He YX; Chow DH; Huang L; Li C; Ke HZ; Ominsky MS; Qin L
    J Orthop Res; 2014 Aug; 32(8):997-1005. PubMed ID: 24782158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerostin Neutralizing Antibody Treatment Enhances Bone Formation but Does Not Rescue Mechanically Induced Delayed Healing.
    Kruck B; Zimmermann EA; Damerow S; Figge C; Julien C; Wulsten D; Thiele T; Martin M; Hamdy R; Reumann MK; Duda GN; Checa S; Willie BM
    J Bone Miner Res; 2018 Sep; 33(9):1686-1697. PubMed ID: 29694687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats.
    Feng G; Chang-Qing Z; Yi-Min C; Xiao-Lin L
    Int Immunopharmacol; 2015 Jan; 24(1):7-13. PubMed ID: 25479724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
    Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model.
    Yee CS; Xie L; Hatsell S; Hum N; Murugesh D; Economides AN; Loots GG; Collette NM
    Bone; 2016 Jan; 82():122-34. PubMed ID: 25952969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
    Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
    J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strongly enhanced levels of sclerostin during human fracture healing.
    Sarahrudi K; Thomas A; Albrecht C; Aharinejad S
    J Orthop Res; 2012 Oct; 30(10):1549-55. PubMed ID: 22508529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing.
    Caetano-Lopes J; Lopes A; Rodrigues A; Fernandes D; Perpétuo IP; Monjardino T; Lucas R; Monteiro J; Konttinen YT; Canhão H; Fonseca JE
    PLoS One; 2011 Feb; 6(2):e16947. PubMed ID: 21347301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study.
    Szulc P; Bertholon C; Borel O; Marchand F; Chapurlat R
    J Bone Miner Res; 2013 Apr; 28(4):855-64. PubMed ID: 23165952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model.
    Virk MS; Alaee F; Tang H; Ominsky MS; Ke HZ; Lieberman JR
    J Bone Joint Surg Am; 2013 Apr; 95(8):694-701. PubMed ID: 23595067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma.
    McDonald MM; Reagan MR; Youlten SE; Mohanty ST; Seckinger A; Terry RL; Pettitt JA; Simic MK; Cheng TL; Morse A; Le LMT; Abi-Hanna D; Kramer I; Falank C; Fairfield H; Ghobrial IM; Baldock PA; Little DG; Kneissel M; Vanderkerken K; Bassett JHD; Williams GR; Oyajobi BO; Hose D; Phan TG; Croucher PI
    Blood; 2017 Jun; 129(26):3452-3464. PubMed ID: 28515094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sclerostin antibody on bone healing.
    Mihara A; Yukata K; Seki T; Iwanaga R; Nishida N; Fujii K; Nagao Y; Sakai T
    World J Orthop; 2021 Sep; 12(9):651-659. PubMed ID: 34631449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin Antibody Increases Callus Size and Strength but does not Improve Fracture Union in a Challenged Open Rat Fracture Model.
    Morse A; McDonald MM; Schindeler A; Peacock L; Mikulec K; Cheng TL; Liu M; Ke HZ; Little DG
    Calcif Tissue Int; 2017 Aug; 101(2):217-228. PubMed ID: 28391431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures.
    Heilmeier U; Carpenter DR; Patsch JM; Harnish R; Joseph GB; Burghardt AJ; Baum T; Schwartz AV; Lang TF; Link TM
    Osteoporos Int; 2015 Apr; 26(4):1283-93. PubMed ID: 25582311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.